NCT07172919 2026-03-06
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
Amgen
Phase 2 Recruiting
Clinical Trials
6 trialsNCT04185883 2025-10-22
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Amgen
Phase 1 Active not recruiting
NCT03360734 2021-07-12
GATTO
Glycotope GmbH
Phase 1 Completed
NCT00610948 2017-05-04
Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT00658658 2016-05-18
Panitumumab in Children With Solid Tumors
Amgen
Phase 1 Completed
NCT00586443 2014-11-19
BEP
Duke University
Phase 1 Completed